Abstract:Transforming growth factor-β (TGF-β) family signaling controls diverse developmental processes and the pathogenesis of many diseases, including cancer and autoimmune and fibrotic diseases. TGF-β and related proteins signal through heteromeric serine-threonine kinase receptors at the cell surface and intracellular effectors called Smads. Advancement in the knowledge of Smads as key TGF-β signal transducers and transcription factors has made it possible to establish a comprehensive model for how the conceptually simple Smad signaling pathways control a broad range of cellular responses in response to a large family of TGF-β ligands (Derynck and Zhang 2003; Shi and Massague 2003; ten Dijke and Hill 2004; Feng and Derynck 2005). Smads orchestrate the transcription of specific gene networks through interactions with cooperating sequence-specific DNA-binding transcription factors, specific DNA response elements, and non-DNA-binding transcription coactivators or corepressors that act to modify local chromatin structure and/or engage the basal transcription machinery (Fig. 1) (for reviews, see Feng and Derynck 2005; Massague et al. 2005). Recent findings also suggest that the regulation of Smad activity through posttranslational modifications such as (de)phosphorylation, ubiquitylation, and sumoylation controls the magnitude and duration of TGF-β responses (Fig. 2) (for reviews, see Feng and Lin 2006; Schilling et al. 2006). This mechanism allows for specific yet robust gene activation or repression in response to TGF-β in a context-dependent manner. This chapter spotlights the properties of Smads as transcription factors. DNA-BINDING PROPERTIES OF SMADS Transcriptional activation is a highly regulated process requiring the rigorous interactions of DNA-binding transcription factors, coactivator proteins, and general transcription...

The mechanism of Smad2 and Smad3 in TGF-β1 signaling

Post-translational regulation of TGF-β receptor and Smad signaling.

Posttranslational Regulation of Smads

Post‐translational Regulation of TGF‐β Receptor and Smad Signaling

Axin and GSK3- Control Smad3 Protein Stability and Modulate TGF- Signaling.

TGF-β Signaling from Receptors to Smads

Smad-dependent and Smad-independent pathways in TGF-β family signalling

TGF-β signaling by Smad proteins

TGF-β Signalling from Cell Membrane to Nucleus Through SMAD Proteins

Signaling of Transforming Growth Factor‐β Family Members Through Smad Proteins

10 Transcriptional Control Via Smads

Regulation of TGF-β Superfamily Signaling by Inhibitory Smads

Functional Characterization of Transforming Growth Factor Β Signaling in Smad2- and Smad3-deficient Fibroblasts*

Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling

Negative Regulation of TGF-β Receptor/smad Signal Transduction

Signaling Inputs Converge on Nuclear Effectors in TGF-β Signaling

SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications

To (TGF)β or not to (TGF)β: Fine-tuning of Smad signaling via post-translational modifications

Interaction of Smad3 and SRF-associated complex mediates TGF-beta1 signals to regulate SM22 transcription during myofibroblast differentiation.